Improving Immunoassay Performance by Antibody Engineering
Open Access
- 1 May 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (5) , 801-802
- https://doi.org/10.1373/clinchem.2005.049221
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Use of an In Vivo Biotinylated Single-Chain Antibody as Capture Reagent in an Immunometric Assay to Decrease the Incidence of Interference from Heterophilic AntibodiesClinical Chemistry, 2005
- The War on Heterophilic Antibody InterferenceClinical Chemistry, 2005
- A Radical Approach Is Needed to Eliminate Interference from Endogenous Antibodies in ImmunoassaysClinical Chemistry, 2005
- Single Domain Antibodies Derived from Dromedary Lymph Node and Peripheral Blood Lymphocytes Sensing Conformational Variants of Prostate-specific AntigenJournal of Biological Chemistry, 2004
- Quantitative, Wide-Range, 5-Minute Point-of-Care Immunoassay for Total Human Chorionic Gonadotropin in Whole BloodClinical Chemistry, 2004
- Immunopeptidometric Assay for Enzymatically Active Prostate-Specific AntigenClinical Chemistry, 2004
- Crystal Structure of an in Vitro Affinity- and Specificity-matured Anti-testosterone Fab in Complex with TestosteronePublished by Elsevier ,2002
- Targeting tumor vasculature with homing peptides from phage displaySeminars in Cancer Biology, 2000
- Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas.Proceedings of the National Academy of Sciences, 1995
- Selection of single-stranded DNA molecules that bind and inhibit human thrombinNature, 1992